Format

Send to

Choose Destination
Open Forum Infect Dis. 2018 Jun 4;5(6):ofy103. doi: 10.1093/ofid/ofy103. eCollection 2018 Jun.

Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS).

Author information

1
Department of Medicine, Denver Health Medical Center, Denver, Colorado.
2
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
3
Department of Medicine, Northwestern University, Chicago, Illinois.
4
Department of Medicine, University of California San Francisco, San Francisco, California.

Abstract

Hepatitis C virus (HCV) recurrence rates were similar between those with HCV/HIV co-infection (0.35/100 person-years) and HCV infection (0.42/100 person-years). Low rates of recurrence likely represent enrollment of an HIV population at low risk for recurrence. Care should be taken not to label all HCV/HIV co-infected patients as being at high risk for HCV recurrence.

KEYWORDS:

HIV; direct acting antivirals; hepatitis C; recurrence

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center